Generic Portal

— Research Explorer

Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis

Research output: Contribution to journal › Article › Academic › peer-review

DOI

https://doi.org/10.1177/13524585211010097
Final published version

Zoë Y. GJ van Lierop
Luuk Wieske
Marleen J. A. Koel-Simmelink
Madhurima Chatterjee
Iris Dekker
Cyra E. Leurs
Eline A. J. Willemse
Bastiaan Moraal
Frederik Barkhof
Filip Eftimov
Bernhard M. J. Uitdehaag
Joep Killestein
Charlotte E. Teunissen

Original language	English
Pages (from-to)	102-110
Number of pages	9
Journal	Multiple sclerosis (Houndmills, Basingstoke, England)
Volume	28
Issue number	1
Early online date	2021
DOIs	https://doi.org/10.1177/13524585211010097
Publication status	Published - Jan 2022

Research areas

Multiple sclerosis, contactin 1, disease activity, disease progression, natalizumab, prediction

ID: 18091789